Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Clearmind Medicine Inc. (CMND) had Return on Tangible Equity of -352.16% for the most recently reported fiscal year, ending 2025-10-31.
| Income Statement Financials | |
-- |
|
$-3.86M |
|
-- |
|
-- |
|
$5.67M |
|
$-5.67M |
|
$1.88M |
|
$-3.79M |
|
$-4.63M |
|
$-3.86M |
|
$-3.86M |
|
$-3.86M |
|
$-4.69M |
|
$-5.67M |
|
$-5.66M |
|
0.13M |
|
0.13M |
|
$-30.35 |
|
$-30.35 |
|
| Balance Sheet Financials | |
$5.95M |
|
-- |
|
$0.14M |
|
$6.08M |
|
$4.89M |
|
-- |
|
-- |
|
$4.89M |
|
$1.19M |
|
$1.10M |
|
$1.19M |
|
0.16M |
|
| Cash Flow Statement Financials | |
$-4.73M |
|
$-0.54M |
|
$2.62M |
|
$6.57M |
|
$3.92M |
|
$-2.65M |
|
$0.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.22 |
|
-- |
|
-- |
|
-- |
|
1.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-323.41% |
|
|
Return on Tangible Equity |
-352.16% |
-63.41% |
|
-323.41% |
|
$7.54 |
|
$-37.25 |
|
$-37.25 |
|